jab-21822
jacobio pharmaceuticals
['jab21822']
#jacobio announces phase i clinical data of #krasg12c #inhibitor #jab21822 at #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.